New COVID-19 XEC variant circulating just before fall
A new COVID-19 variant, XEC, has arrived just before fall.
Sep 23, 2024
0
91
Organic Chemical: remdesivir
Medical news and research articles
Antiviral-resistant variants of SARS-CoV-2 can emerge in immunocompromised people
Individuals with compromised immunity and persistent COVID-19 infections can harbor drug-resistant variants of the SARS-CoV-2 virus, which have the potential to spread to the general population found researchers at Weill ...
Sep 18, 2024
0
44
Analysis shows how unproven therapeutics were portrayed in the media during the early phase of COVID-19 pandemic
A new study from researchers at Wake Forest University School of Medicine is shedding light on how scientific evidence and the uncertainty surrounding three unproven therapeutics were portrayed by the U.S. news media during ...
Aug 29, 2024
0
40
New study looks at drug exposures of COVID-19 therapy for pregnant people
A new study provides important insights into the pharmacokinetics and safety of intravenous remdesivir in treating the SARS-CoV-2 coronavirus in pregnant women.
Aug 13, 2024
0
42
Researchers create brain organoid to investigate effects of COVID-19 in people with Down syndrome
A first-of-its kind brain organoid grown at The University of Queensland has helped researchers identify therapies that reduce the impact of COVID-19 on people with Down syndrome.
Jun 6, 2024
0
34
Oral nucleoside antiviral is progressing toward future pandemic preparedness
Obeldesivir (GS-5245), a novel investigational small molecule oral antiviral, represents a new tool in the ongoing effort to prepare for future pandemics.
Jun 3, 2024
0
51
Study reports new compound that halts replication of COVID by targeting 'Mac-1' protein in cell models
Research appearing in the Journal of Medicinal Chemistry shows for the first time SARS-CoV-2, the virus responsible for COVID-19, can be inhibited from replicating in living cell cultures using a compound that targets "Mac-1," ...
Apr 25, 2024
0
59
Significant global variation in COVID-19 guidelines: Most countries recommend at least one treatment that doesn't work
National clinical guidelines for the treatment of COVID-19 vary significantly around the world, with under-resourced countries the most likely to diverge from gold standard (World Health Organization; WHO) treatment recommendations, ...
Apr 22, 2024
1
79
Researchers predict real-world SARS-CoV-2 evolution by monitoring mutations of viral isolates
Junior Associate Professor Kazuo Takayama (Department of Cell Growth and Differentiation) and a collaborative team of researchers in Japan recently characterized SARS-CoV-2 collected from a persistent COVID-19 patient to ...
Apr 3, 2024
0
53
Risk profile tool provides clearer insight on hospitalized COVID-19 patients who benefit most from baricitinib treatment
A post-hoc analysis of ACTT-2 (Adaptive COVID-19 Treatment Trial-2) found that the use of a risk profile may more precisely characterize high-risk patients who may benefit from the use of baricitinib. The analysis is published ...
Feb 26, 2024
0
29
